George, Sarah - University of Bristol - School of Clinical Sciences

个人简介

Born in Bristol, Sarah Jane George graduated in Applied Biology from University of Wales in Cardiff in 1991. Following a PhD with Professor Andrew Newby at the University of Wales College of Medicine in Cardiff - entitled ‘Growth Factors and Smooth Muscle Cell Proliferation@ - she moved to the University of Bristol to carry out postdoctoral studies with Professor Gianni Angelini.

研究领域

Cardiovascular Signalling

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Williams, H, Mill, C, Monk, B, Curtis, S, Johnson, J & George, S, 2016, ‘Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration’. Arteriosclerosis, Thrombosis and Vascular Biology, vol 36., pp. 1417-1424 Schumacker, NW, Angelini, G, George, S & Ascione, R, 2016, ‘Improving cellularisation of tissue endgineered vascular grafts using functionalised peptide hydrogels’. Atherosclerosis, vol 244., pp. e10 Zakkar, M, George, SJ & Ascione, R, 2016, ‘Should chronic total occlusion be treated with coronary artery bypass grafting?: Chronic total occlusion should be treated with coronary artery bypass grafting’. Circulation, vol 133., pp. 1807-1816 Zakkar, M, George, SJ & Ascione, R, 2016, ‘Response to Weintraub and Garratt’. Circulation, vol 133., pp. 1826 Sulaiman, N, Satta, S, George, S, Suleiman, S & Ascione, R, 2016, ‘Effect of decellularization protocol of human saphenous veins on cytotoxicity and matrix component’. Atherosclerosis, vol 244., pp. e11-e12 Di Gregoli, K, George, SJ, Jackson, CL, Newby, AC & Johnson, JL, 2015, ‘Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion’. Cardiovascular Research, vol 109., pp. 318-330 Lyon, CA, Wadey, KS & George, SJ, 2015, ‘Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening’. Current Vascular Pharmacology. Iacobazzi, D, Suleiman, M-S, Ghorbel, M, George, SJ, Caputo, M & Tulloh, RM, 2015, ‘Cellular and molecular basis of RV hypertrophy in congenital heart disease’. Heart. Lyon, CA, Johnson, JL, White, S, Sala-Newby, GB & George, SJ, 2014, ‘EC4, a truncation of soluble N-cadherin, reduces vascular smooth muscle cell apoptosis and markers of atherosclerotic plaque instability’. Molecular Therapy - Methods & Clinical Development , vol 1. Monk, BA, Williams, H, Mill, CEJ, Lyon, CA, Johnson, JL, Angelini, GD & George, SJ, 2014, ‘DYSFUNCTIONAL WNT SIGNALLING IN AGEING: IMPLICATIONS FOR CARDIOVASCULAR DISEASE’., pp. E6-E6